| ||
Orexigen's Stock Price Goes on Crash Diet Barron's (blog) By Johanna Bennett Orexigen Therapeutics (OREX) shares took a nose dive this afternoon after the drug maker announced it was shelving its bid to get US approval for its experimental diet pill Contrave, citing unreasonable demands by regulators. ... See all stories on this topic » | ||
| ||
| ||
OHSU research points to high-fat diet as culprit in some birth defects Portland Tribune By Peter Korn The typical high-fat American diet may be responsible for increased stillborns and serious birth defects regardless of whether pregnant women are themselves obese or slender, according to a new animal study at Oregon Health & Science ... See all stories on this topic » | ||
| ||
High-Fat Diets OK for Obese Individuals? KGO-AM Doctors at Johns Hopkins University studied whether a low-carb, high-fat diet posed a serious health risk to obese individuals, since high-fat foods may increase risk of clogged arteries. They divided 46 overweight or obese participants into two ... See all stories on this topic » | ||
|
This as-it-happens Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment